# What U.S. export-license review policy will apply to direct exports of NVIDIA H200 accelerators from the United States to otherwise eligible civilian commercial customers in mainland China on June 30, 2027?

Canonical URL: https://preseen.com/reports/213b45a5-7a85-4100-871a-3c4c7c7c40ea/what-u-s-export-license-review-policy-will-apply-to-direct-exports-of-nvidia-h20
Markdown URL: https://preseen.com/reports/213b45a5-7a85-4100-871a-3c4c7c7c40ea/markdown

## Forecast

Top outcome: Case-by-case review — individual licenses required without a governing presumption of approval or denial at 72.6%. Other leading outcomes: Presumption of denial — individual licenses remain legally possible, but denial is the governing default: 17.0%; Categorical prohibition — no lawful commercial authorization pathway for the covered exports: 6.0%; Other or mixed policy — materially different policy categories apply across covered customer classes, or no generally applicable standard fits the preceding categories: 2.4%; Presumption of approval — individual licenses required, with approval as the governing default: 1.5%.

Generated: November 13, 2026 at 11:50 AM UTC

## Analysis

## Executive Summary

**Case-by-case review is the leading outcome, at 72.6%.** The forecast favors survival of the conditional H200 licensing pathway through June 30, 2027—even if Washington adds oversight, tightens safeguards or restricts particular intermediaries. A return to **presumption of denial, at 17.0%**, is the main alternative.

| Policy at the snapshot | Probability |
|---|---:|
| Case-by-case review — individual licenses required without a governing presumption of approval or denial | 72.6% |
| Presumption of denial — individual licenses remain legally possible, but denial is the governing default | 17.0% |
| Categorical prohibition — no lawful commercial authorization pathway for the covered exports | 6.0% |
| Other or mixed policy — materially different policy categories apply across covered customer classes, or no generally applicable standard fits the preceding categories | 2.4% |
| Presumption of approval — individual licenses required, with approval as the governing default | 1.5% |
| Permission without an individual license — a generally available authorization, license exception or removal of the license requirement permits covered exports | 0.5% |

These probabilities concern the **legally operative review standard at 11:59:59 p.m. America/New_York time on June 30, 2027**. They do not predict individual approvals, shipment volumes or Chinese import permission. Case-by-case review preserves a route to authorization; it does not guarantee approval.

## Key drivers

### The current pathway has no scheduled expiration

The January 15, 2026 final rule established conditional case-by-case review for qualifying direct H200 exports. The question assumes applicants satisfy its supply-protection, screening, security, testing and shipment-allocation requirements. The denial presumption applicable to noncompliant applications therefore does not control this forecast.

The consolidated Export Administration Regulations—the U.S. export-control rules—checked during the research were current through November 10, 2026 and retained that pathway. Searches through the forecast date found no superseding H200 review-policy instrument. The rule has no scheduled sunset.

That supports continuity, but not procedural complacency: the rule invokes statutory exemptions from ordinary advance public rulemaking procedures. A reversal need not spend months in a public proposal stage.

### The strongest published Senate proposal preserves H200 licensing

The most consequential legislative distinction is between versions of **AI OVERWATCH**, a proposed advanced-chip oversight framework.

The July 14, 2026 Senate defense-bill manager’s package requires individual licenses, certifications and congressional notice. Its mandatory-denial threshold is above the H200 envelope identified in the current rule, and it omits the older blanket licensing freeze pending submission of an AI strategy. Enacted unchanged, that formulation would tighten oversight without itself replacing the H200 case-by-case baseline.

Older OVERWATCH language and SAFE Chips provide genuine prohibition pathways. Their proposed requirements to deny every covered application would mean categorical prohibition while operative—not merely a presumption of denial. But those proposals were not effective law in the material checked.

### Security concerns make broad tightening a material risk

Investigative reporting found apparently empty premises at approved H200 handlers and ownership connections to restricted firms. Those findings challenge the reliability of screening, rather than merely identifying a paperwork problem. They support retaining meaningful probability for a countrywide restrictive reset, although they are reporting findings, not adjudicated conclusions about every licensee.

Jensen Huang’s resignation, effective November 11, also removes an influential advocate for the opening. Bipartisan demands for stronger controls increase the political pressure to act.

### Targeted enforcement remains more strongly supported than wholesale reversal

President Trump personally announced the conditional H200 opening and distinguished H200 from more advanced products. His reported encouragement to Huang in November, and his public refusal to treat the intelligence allegations as established, weaken the case that Huang’s departure automatically ends the policy bargain.

The concrete executive dispute reported by CNN concerned placing Megaspeed on the Entity List, a list imposing restrictions on named parties. Other reported tightening efforts concerned diversion and overseas computing access. Such actions can be substantial while leaving case-by-case review intact for unrelated, otherwise eligible mainland customers.

## Scenarios

The forecast weighs three broad paths. They distinguish changes in the governing legal standard from tougher conditions within the same standard.

| Scenario | Why it receives its relative weight | How it leads to an outcome |
|---|---|---|
| **Managed continuity with targeted enforcement** | Dominant because the existing pathway has no sunset, the published July Senate formulation preserves it, and much of the concrete enforcement agenda targets intermediaries or overseas access. | Case-by-case review survives, potentially with tighter screening, testing, tracking, certifications or congressional oversight. A temporary interruption ending before the snapshot could also lead here. |
| **Broader restrictive reset** | The principal downside because concerns about screening, bipartisan pressure and weakened commercial advocacy could prompt a countrywide response. | Presumption of denial is the leading restrictive alternative: it restores a familiar default while preserving discretion to authorize exceptions. Categorical prohibition requires the stronger step of eliminating every covered commercial pathway, through legislation, regulation or an operative blanket freeze. |
| **Structural redesign or easing** | A small residual because broader advanced-chip rulemaking remains possible, but the current framework and inspected Senate proposal favor transaction-specific control rather than broad permission. | Different legal standards for materially distinct eligible customer classes could produce Other or mixed policy. An explicit favorable default could produce presumption of approval; a generally available license-free route for the entire covered class could produce permission without an individual license. |

Different paperwork or security requirements alone would not produce a mixed regime. Nor would overlapping rules if one legally controlling standard determines the result.

## Implications

- **Plan around conditional individual licensing, not assured commercial access.** The leading outcome preserves an application route, but does not establish predictable approvals or China revenue.
- **Compliance remains central even under continuity.** Stronger screening, independent testing, supply assurances and allocation controls can increase transaction friction without changing the forecast’s policy category.
- **Keep a distinct restrictive contingency.** A denial presumption preserves legal discretion; categorical prohibition removes the pathway entirely. Those outcomes have different consequences for new covered transactions.
- **Separate legal policy from commercial signals.** Low shipments, administrative delays, Chinese import restrictions and revocation of particular licenses do not establish that the generally applicable review category has changed.

## Signs to watch

| Event or development | What would matter | Direction for the forecast |
|---|---|---|
| **November 17, 2026: requested confirmation of records preservation** in the Warren–Coons inquiry | The deadline is an investigative milestone, not a promised public disclosure. Subsequent findings could distinguish misconduct by particular intermediaries from systemic screening failure. | Isolated failures would support case-by-case continuity; evidence that compliant direct exports cannot be secured would favor denial or prohibition. |
| **December 3 and December 10, 2026: requested Senate Banking testimony** from Huang and Commerce Secretary Lutnick, respectively | CNBC reported that Lutnick agreed to appear; Huang’s appearance was requested rather than confirmed in the material read. Testimony could clarify both security failures and the administration’s intended response. | A targeted-enforcement position would strengthen continuity. An explicit commitment to withdraw the countrywide H200 pathway would favor restrictive outcomes. Such a commitment would make the forecast worth rerunning. |
| **Final defense-bill negotiations, with no fixed completion date established in the research** | Whether the final text retains the July Senate approach, restores a strategy-linked freeze, or adopts broader mandatory denial. | The July approach supports case-by-case review. A blanket freeze or must-deny provision favors prohibition if still operative at the snapshot. Publication of agreed text would settle a major uncertainty and warrant rerunning the forecast. |
| **A new export-control rule, potentially announced with little warning** | The operative review language, scope and effective date—not merely a tougher political description. The broader AI Action Plan rulemaking remains a possible vehicle. | Stronger conditions alone support continuity. A denial default favors presumption of denial; elimination of every pathway favors prohibition; a broad license exception favors license-free permission. A final binding rule warrants rerunning the forecast. |
| **New security findings or presidential reassessment** | Credible evidence of unavoidable compromise in otherwise compliant exports, or an explicit presidential repudiation of the H200 bargain. A Commerce personnel change matters most if accompanied by a policy mandate. | These developments would favor restrictive outcomes. A substantial intermediary-focused crackdown that expressly preserves compliant direct sales would strengthen case-by-case review. |
| **An operative court order before June 30, 2027** | Its actual scope and effect on the applicable rules. A stayed or vacated measure does not necessarily restore a particular predecessor policy. | The direction depends on the order. Any order materially affecting the H200 pathway would warrant rerunning the forecast. |

Changes effective after June 30 do not change the answer. Public evidence released by September 30, 2027 may clarify the snapshot regime, but does not extend the policy horizon.

## Research and methodology

The forecast uses a **judgmental scenario model**: it weighs legal continuity, a restrictive reset and structural redesign, then maps each path to the question’s policy categories. It does not extrapolate from individual approval rates. The short, reversible H20/H200 licensing history informed how quickly access can change, but was not treated as a reliable statistical transition rate.

The most influential sources were:

- **Binding regulatory text:** the [January 15 final rule](https://www.govinfo.gov/content/pkg/FR-2026-01-15/pdf/2026-00789.pdf) and [15 CFR 742.6](https://www.ecfr.gov/current/title-15/subtitle-B/chapter-VII/subchapter-C/part-742/section-742.6). These establish the conditional pathway, its controlling review standard and the absence of a scheduled sunset.
- **Competing legislative texts:** the [July 14 Senate manager’s package, section 6243](https://www.govinfo.gov/content/pkg/CREC-2026-07-14/html/CREC-2026-07-14-pt1-PgS3947.htm), [standalone Senate OVERWATCH bill](https://www.govinfo.gov/content/pkg/BILLS-119s4456is/html/BILLS-119s4456is.htm) and [SAFE Chips bill](https://www.govinfo.gov/content/pkg/BILLS-119s3374is/html/BILLS-119s3374is.htm). Comparing their operative provisions was crucial to distinguishing oversight from prohibition.
- **Corporate and official political records:** [NVIDIA’s leadership filing](https://www.sec.gov/Archives/edgar/data/1045810/000104581026000082/nvda-20261111.htm), the [Banks–Warren statement](https://www.banks.senate.gov/news/press-releases/sens-banks-warren-statement-on-national-security-concerns-surrounding-nvidia/) and [Trump’s original H200 announcement](https://www.presidency.ucsb.edu/documents/truth-social-posts-december-8-2025). These establish the leadership change, legislative pressure and presidential ownership of the opening.
- **Investigative and executive-branch reporting:** the [republished New York Times handler investigation](https://www.businesstimes.com.sg/international/global/empty-offices-ties-blacklisted-firms-inside-chinese-companies-us-cleared-nvidia-chips/), [CNN’s Megaspeed report](https://krdo.com/politics/cnn-us-politics/2026/11/11/bessent-confronts-lutnick-over-not-labeling-nvidia-customer-a-national-security-threat-sources-say/) and [Reuters reporting on Trump’s encouragement to Huang](https://www.channelnewsasia.com/business/trump-had-urged-jensen-huang-fight-his-job-new-york-times-reports-6547941). These informed the balance between systemic reversal risk and targeted enforcement. Allegations and unnamed-source accounts were not treated as established legal findings.
- **Policy pipeline and oversight calendar:** the [AI Action Plan regulatory agenda entry](https://www.reginfo.gov/public/do/eAgendaViewRule?RIN=0694-AJ90&operation=OPERATION_PRINT_RULE&pubId=202510), [Warren–Coons records request](https://www.banking.senate.gov/newsroom/minority/senators-warren-and-coons-direct-lutnick-rubio-and-miller-to-preserve-nvidia-records-following-reports-of-foreign-intelligence-operation-targeting-ceo-jensen-huang) and [CNBC’s hearing report](https://www.cnbc.com/2026/11/13/nvidia-scandal-lutnick-chip-sales.html). These identify possible vehicles and milestones, not operative policy changes.

## Limitations

The largest unresolved information gap is the final negotiated legislative language. No later public compromise text or underlying White House technical-assistance document was obtained; public demands for stronger controls do not reveal the eventual terms.

The legal check also has limits. The consolidated regulations retrieved were current through November 10, leaving a short publication gap supplemented by Federal Register searches. No superseding H200 measure or operative judicial order was found, but court-docket coverage was not exhaustive. Access to some original reporting was partial and relied on syndication.

These are judgmental probabilities, not estimates supported by a long statistical record. If the eligible public record ultimately leaves material uncertainty about the operative snapshot regime, the question requires annulment rather than inference from licensing outcomes.

## Sources

- Domain Expert Search (mcp)
  > Found 7 domain experts for 'United States semiconductor export controls China H200 EAR legal review congressional NDAA AI OVERWATCH November 2026':
- Federalregister (mcp)
  > Federal Register Search Results (as of 2026-11-13)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/01/15/2026-00789/revision-to-license-review-policy-for-advanced-computing-commodities) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/11/12/2026-23003/housing-and-community-development-act-of-1980-verification-of-eligible-status) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/11/09/2026-22792/medicare-drug-price-negotiation-program-and-medicare-prescription-drug-benefit-program) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/11/09/2026-22750/calendar-year-2027-home-health-prospective-payment-system-hh-pps-rate-update-requirements-for-the-hh) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/11/09/2026-22743/medicare-and-medicaid-programs-cy-2027-payment-policies-under-the-physician-fee-schedule-and-other) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/11/06/2026-22739/medicare-program-hospital-outpatient-prospective-payment-and-ambulatory-surgical-center-payment) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/11/03/2026-22443/streamlining-contested-adjudications-in-licensing-proceedings) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/10/30/2026-22194/medicare-program-cy-2027-changes-to-the-end-stage-renal-disease-esrd-prospective-payment-system) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/10/30/2026-22174/accreditation-innovation-and-modernization-the-secretarys-recognition-of-accrediting-agencies) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/10/28/2026-21943/health-data-technology-and-interoperability-onc-deregulatory-actions-to-unleash-prosperity) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/10/23/2026-21706/implementing-the-guiding-and-establishing-national-innovation-for-us-stablecoins-act-for-the) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/10/19/2026-21319/elimination-of-time-in-grade) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/10/06/2026-20447/transparency-in-coverage) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/10/02/2026-20281/global-benchmark-for-efficient-drug-pricing-globe-model) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/09/30/2026-19964/the-safer-affordable-fuel-efficient-safe-vehicles-rule-iii-for-model-years-2022-to-2031-passenger) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/09/25/2026-19652/implementation-of-training-requirements-for-personnel-serving-on-us-flagged-passenger-ships-that) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/09/14/2026-18778/review-of-the-commissions-assessment-and-collection-of-regulatory-fees-for-fiscal-year-2026) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/08/21/2026-17114/rescission-of-executive-order-11246-implementing-regulations) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/08/11/2026-16313/mandatory-electronic-filing-e-filing) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/08/04/2026-15833/medicare-program-hospital-inpatient-prospective-payment-systems-for-acute-care-hospitals-ipps-and) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/08/03/2026-15686/medicare-program-fy-2027-hospice-wage-index-and-payment-rate-update-and-hospice-quality-reporting) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/08/03/2026-15666/reduction-in-force-appeals) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/08/03/2026-15652/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/07/31/2026-15588/medicare-program-fy-2027-inpatient-psychiatric-facilities-prospective-payment-system-rate-update) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/07/31/2026-15562/medicare-program-prospective-payment-system-and-consolidated-billing-for-skilled-nursing-facilities) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/07/27/2026-15123/review-of-submarine-cable-landing-license-rules-and-procedures-to-assess-evolving-national-security) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/07/17/2026-14509/margin-requirements-for-uncleared-swaps-for-swap-dealers-and-major-swap-participants) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/07/17/2026-14439/establishing-a-fixed-time-period-of-admission-and-an-extension-of-stay-procedure-for-nonimmigrant) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/07/14/2026-14132/enhanced-favorable-treatment-for-the-united-arab-emirates-under-the-export-administration) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/07/02/2026-13420/revised-medical-criteria-for-evaluating-cardiovascular-disorders) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/07/01/2026-13286/accountability-in-higher-education-and-access-through-demand--driven-workforce-pell-student-tuition) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/06/17/2026-12190/priority-mail-express-and-priority-mail-open-and-distribute-parcel-mailings-discontinued) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/06/10/2026-11648/oil-and-gas-and-sulfur-operations-in-the-outer-continental-shelf-documents-incorporated-by-reference) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/06/03/2026-11094/medicaid-program-community-engagement-requirement-for-certain-individuals) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/06/02/2026-11003/new-mailing-standards-for-domestic-mailing-services-products) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/06/01/2026-10890/medicare-program-alternative-payment-model-updates-and-the-increasing-organ-transplant-access-iota) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/05/20/2026-10050/patient-protection-and-affordable-care-act-hhs-notice-of-benefit-and-payment-parameters-for-2027-and) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/05/19/2026-10013/accountability-in-higher-education-and-access-through-demand-driven-workforce-pell-pell-grant) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/05/01/2026-08556/reimagining-and-improving-student-education-federal-student-loan-program-final-regulations) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/05/01/2026-08494/small-business-lending-under-the-equal-credit-opportunity-act-regulation-b) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/04/29/2026-08298/regulatory-capital-rule-community-bank-leverage-ratio-framework) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/04/16/2026-07343/deleting-obsolete-and-duplicative-wireline-rules) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/04/06/2026-06600/medicare-program-contract-year-2027-and-certain-contract-year-2026-policy-and-technical-changes-to) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/03/24/2026-05716/order-no-919-virtualization-reliability-standards) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/03/24/2026-05676/administrative-simplification-adoption-of-standards-for-health-care-claims-attachments-transactions) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/03/12/2026-04797/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/02/17/2026-03054/great-lakes-pilotage-rates-2026-annual-review-and-revisions-to-methodology) (tool)
- [federalregister.gov](https://www.federalregister.gov/documents/2026/01/21/2026-01044/deep-seabed-mining-revisions-to-regulations-for-exploration-license-and-commercial-recovery-permit) (tool)

## Question Details

This question asks which generally applicable U.S. export-license review policy will be legally in force at 11:59:59 p.m. America/New_York time on June 30, 2027, for direct exports from the United States of standard NVIDIA H200 accelerators to otherwise eligible civilian commercial customers in mainland China. The January 15, 2026 final rule established conditional case-by-case review for covered H200 exports, replacing the presumption of denial when specified requirements are satisfied. Those requirements include certifications protecting U.S. supply and production capacity, a China-and-Macau aggregate shipment limit measured in total processing performance relative to corresponding U.S. shipments, customer screening and independent testing in the United States. This establishes a conditional licensing pathway, not guaranteed approval of individual applications. (govinfo.gov) The forecast concerns whether that policy category survives or changes at the snapshot, rather than whether particular licenses are issued or shipments occur. Resolution will occur after September 30, 2027, using only public evidence available through that date.

### Resolution Criteria

Resolve to the single option describing the operative legal regime at 11:59:59 p.m. America/New_York time on June 30, 2027, for new applications or new exports within the fixed scope. Assume standard, unmodified H200 accelerators, direct U.S.-to-mainland-China exports, unsanctioned civilian commercial end users, no prohibited end use, and applicants satisfying applicable procedural, certification, security and testing conditions. Determine the outcome using the Export Administration Regulations applicable at the snapshot, Federal Register rules and other binding U.S. legal instruments, together with operative court orders affecting their applicability. Relevant starting provisions include 15 CFR 742.6, 744.23 and supplement no. 2 to part 748, including any successors. (govinfo.gov) Give controlling legal instruments and their effective dates priority over summaries, announcements or press reporting. Apply judicial stays, injunctions, vacatur and superseding measures according to their actual scope and legal effect; do not assume that a stayed or vacated rule automatically reinstates a particular predecessor regime. Categorical prohibition means no lawful commercial authorization pathway exists for the covered class under the operative regime. Presumption of denial means individual licensing remains legally available but denial is the governing default. Case-by-case review means individual licenses are required and assessed without a governing presumption of approval or denial. Presumption of approval means individual licenses are required but approval is the governing default. Permission without an individual license means a generally available authorization, license exception or absence of a license requirement permits covered exports without transaction-specific individual licensing. Other or mixed policy applies when materially different policy categories govern different otherwise eligible covered customer classes, or when the established operative regime fits none of the preceding categories. Resolve after the evidence cutoff of 11:59:59 p.m. America/New_York time on September 30, 2027, using only evidence publicly available by that cutoff. Evidence published after the snapshot but by the cutoff may clarify which regime was legally operative at the snapshot. Subsequent policy changes do not alter the outcome. If the eligible public record leaves unresolved material uncertainty about which policy category was operative at the snapshot, annul rather than infer a category from licensing outcomes. A verifiably mixed or unusual regime resolves to Other or mixed policy, not annulment.

### Fine Print

This is an unconditional forecast of the policy at a fixed future time, not a question conditional on a license application, approval or shipment occurring. Mainland China excludes Hong Kong and Macau; Macau remains relevant only where a governing aggregate limit includes it. Exclude reexports, in-country transfers, modified or China-specific substitute chips, and transactions independently disqualified by sanctions or prohibited end-user or end-use restrictions. Tighter or looser documentation, testing, screening, supply-priority, quantity or performance-allocation conditions do not alone change the policy category. Evaluate the governing review standard for applications satisfying such conditions, rather than temporary exhaustion of a quota or an individual applicant's inability to comply. A binding measure that eliminates every commercial authorization pathway for the entire covered class nevertheless counts as categorical prohibition, regardless of its label. Different conditions within the same review category do not constitute a mixed policy. Where overlapping rules apply to the same transaction, use the legally controlling combined result rather than treating overlap alone as mixed policy. A generally available license-free pathway takes precedence over an optional individual-license route for the same covered class; a license-free pathway limited to one materially distinct customer class while other covered classes require individual licenses constitutes mixed policy. Existing individual licenses, grandfathering limited to previously authorized transactions, isolated waivers, actual approval rates, administrative delays, Chinese import restrictions and commercial demand do not determine the category for new covered transactions. Announced measures with effective dates after the snapshot do not count. Evidence first made public after September 30, 2027, America/New_York time is excluded, even if it concerns the snapshot. The evidence cutoff limits the record used to establish the snapshot regime; it does not move the policy snapshot to September 30, 2027.
